Oxybutynin and Ileitis aggravated - a phase IV clinical study of FDA data

Summary:

Ileitis aggravated is reported as a side effect among people who take Oxybutynin (oxybutynin), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Pantoprazole, and have Pain.

The phase IV clinical study analyzes which people have Ileitis aggravated when taking Oxybutynin. It is created by eHealthMe based on reports of 22,833 people who have side effects when taking Oxybutynin from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Ileitis aggravated?

Ileitis aggravated (serious inflammation of the ileum) is found to be associated with 1,132 drugs and 412 conditions by eHealthMe. Check the latest studies of Ileitis aggravated.

On Aug, 12, 2026

22,833 people reported to have side effects when taking Oxybutynin.
Among them, 79 people (0.35%) have Ileitis aggravated.

Could Oxybutynin cause Ileitis aggravated?

Among these 79 people:

How long have people been on Oxybutynin when they have Ileitis aggravated? *

What is the gender of people who have Ileitis aggravated when taking Oxybutynin? *

female: 76.56 %
male: 23.44 %

What is the age of people who have Ileitis aggravated when taking Oxybutynin? *

What are other drugs people take besides Oxybutynin? *

What are other side effects people have besides Ileitis aggravated? *

Drug Intolerance (drug sensitivity): 14 people, 17.72%
Poor Venous Access: 13 people, 16.46%
Diarrhea: 13 people, 16.46%
Hair Loss: 13 people, 16.46%
High Blood Pressure: 12 people, 15.19%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 11 people, 13.92%
Drug Hypersensitivity: 11 people, 13.92%
Dyslipidaemia (abnormal amount of lipids): 11 people, 13.92%
Hypotension (abnormally low blood pressure): 11 people, 13.92%
Heart Rate Irregular: 11 people, 13.92%

What are the existing conditions these people have? *

Pain: 12 people, 15.19%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 12.66%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 12.66%
Back Pain: 7 people, 8.86%
Hypersensitivity: 7 people, 8.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.33%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 5 people, 6.33%
High Blood Pressure: 5 people, 6.33%
Depression: 4 people, 5.06%
Micturition Disorder (disease of passing urine): 4 people, 5.06%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and have Ileitis aggravated?

- Check whether Ileitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxybutynin:

Oxybutynin (23,143 reports)

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ileitis aggravated:

Ileitis aggravated (1,132 drugs)

Browse all the conditions that are associated with Ileitis aggravated:

Ileitis aggravated (412 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.